IGF-1 DES Dosage Calculator
IGF-1 DES (des(1-3) Insulin-like Growth Factor-1) is a 67-amino acid truncated analog of IGF-1, missing the first three N-terminal amino acids (Gly-Pro-Glu).
50mcg · Daily
Summary: Add 1mL BAC water to your 0.1mg vial. Draw to 50.0 units on a U-100 syringe for a 50mcg dose. This vial will last 2 doses.
Cycle Planner
IGF-1 DES Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~20-30 minutesDisclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
IGF-1 DES Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50mcg | Daily |
| Moderate | 80mcg | Daily |
| Aggressive | 120mcg | Daily |
Note: Truncated IGF-1 analog missing first 3 amino acids (des(1-3)IGF-1). Does not bind IGF binding proteins, giving it ~10x greater potency than native IGF-1 but a very short half-life. Inject intramuscularly into the target muscle immediately post-workout for site-specific growth. Use insulin syringes for accurate dosing. Monitor blood sugar closely.
About IGF-1 DES
IGF-1 DES (des(1-3) Insulin-like Growth Factor-1) is a 67-amino acid truncated analog of IGF-1, missing the first three N-terminal amino acids (Gly-Pro-Glu). This structural modification eliminates binding to all six IGF binding proteins (IGFBPs), meaning the entire dose remains bioactive in free form. The result is roughly 10-fold greater potency than native IGF-1, but with a half-life of only 20-30 minutes. This rapid clearance makes IGF-1 DES uniquely suited for localized intramuscular injection, allowing site-specific muscle hypertrophy and hyperplasia without prolonged systemic IGF-1 elevation. It activates the IGF-1 receptor (IGF-1R) and downstream PI3K/Akt/mTOR and MAPK/ERK signaling to drive protein synthesis, satellite cell proliferation, and new muscle fiber formation.